(1-((2S,3S,5S)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl ((3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl) succinate

ID: ALA5316193

Chembl Id: CHEMBL5316193

Max Phase: Preclinical

Molecular Formula: C32H43N5O12

Molecular Weight: 689.72

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cn([C@H]2C[C@H](n3cc(COC(=O)CCC(=O)O[C@@H]4O[C@@H]5O[C@@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C32H43N5O12/c1-16-5-6-21-18(3)28(46-29-32(21)20(16)9-10-31(4,47-29)48-49-32)45-26(40)8-7-25(39)43-15-19-13-37(35-34-19)22-11-24(44-23(22)14-38)36-12-17(2)27(41)33-30(36)42/h12-13,16,18,20-24,28-29,38H,5-11,14-15H2,1-4H3,(H,33,41,42)/t16-,18-,20+,21+,22+,23-,24-,28-,29-,31-,32-/m1/s1

Standard InChI Key:  GABIIRGPDXXDDI-LACVDWCXSA-N

Alternative Forms

  1. Parent:

    ALA5316193

    ---

Associated Targets(Human)

KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 689.72Molecular Weight (Monoisotopic): 689.2908AlogP: 1.53#Rotatable Bonds: 9
Polar Surface Area: 204.55Molecular Species: NEUTRALHBA: 16HBD: 2
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.96CX Basic pKa: CX LogP: 2.50CX LogD: 2.50
Aromatic Rings: 2Heavy Atoms: 49QED Weighted: 0.28Np Likeness Score: 1.46

References

1. Gao F, Sun Z, Kong F, Xiao J..  (2020)  Artemisinin-derived hybrids and their anticancer activity.,  188  [PMID:31945642] [10.1016/j.ejmech.2020.112044]

Source